Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs.
about
New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical TrialsDeveloping an in vitro screening assay platform for evaluation of antifibrotic drugs using precision-cut liver slices.The effect of antifibrotic drugs in rat precision-cut fibrotic liver slices.Experimental models of liver fibrosisTargeting the PDGF-B/PDGFR-β Interface with Destruxin A5 to Selectively Block PDGF-BB/PDGFR-ββ Signaling and Attenuate Liver FibrosisIdiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays.Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approach.The role of chemokines in hepatitis C virus-mediated liver diseaseThe application of engineered liver tissues for novel drug discovery.Precision-cut intestinal slices: alternative model for drug transport, metabolism, and toxicology research.Metabolomics combined with pattern recognition and bioinformatics analysis methods for the development of pharmacodynamic biomarkers on liver fibrosis.Murine precision-cut liver slices (PCLS): a new tool for studying tumor microenvironments and cell signaling ex vivo.Challenges on the road to a multicellular bioartificial liver.Maintenance of drug metabolism and transport functions in human precision-cut liver slices during prolonged incubation for 5 days.Hepatic stellate cells as key target in liver fibrosis.Precision-cut rat, mouse, and human intestinal slices as novel models for the early-onset of intestinal fibrosisPrecision-Cut Kidney Slices as a Tool to Understand the Dynamics of Extracellular Matrix Remodeling in Renal Fibrosis.Precision-cut kidney slices (PCKS) to study development of renal fibrosis and efficacy of drug targeting ex vivo.Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system.Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis
P2860
Q26772800-55BB46EB-C083-44A8-BFB8-6C5430CD012DQ34976113-5B205F32-97B6-4FB4-83C0-BBBE29EBCF1BQ35154961-AFA1BAC6-9C0D-44AA-9BAD-02525E84EA9CQ36442525-F6F9CEB7-72EF-499D-9CB7-8FE7FB33BB04Q37009087-2538E2CB-1C54-4F8B-B04F-B7E630E74153Q37590883-0EC42910-F9BD-4ECF-BDA3-7B3822C5E279Q37651374-1C8F68D3-C0FC-48C3-A962-9CE4D485437AQ38197441-DE9BC07F-4092-4B6F-A22B-D2F7A329ED9BQ38404573-C89A2DE9-E395-42F2-9065-211C111FFEF7Q38691889-F573DA50-6F81-444E-BCE6-3298DA389D79Q38696814-D2D828C1-CC43-4D54-AF62-8CC887260A03Q38942158-1F1FD842-45D8-415B-9FBF-F32E2728E6C7Q39036360-6C450C80-AFE4-48E0-98B1-283373871461Q39310632-1CA27C17-4918-462D-B835-698521A54040Q40200602-204CB4EB-32A2-43A6-B784-D5A099A84086Q40487416-896A74FA-B121-438C-881F-384CAC1014B4Q41834482-E2D4847D-FF83-48D5-834C-66D903107C7AQ41839678-3F08F41F-015D-43AC-8E8D-4A88939AD3B5Q45048681-90D046F4-9E47-435C-A495-FBA0FA49E895Q58737862-64F63811-7D47-4DB6-AE3F-16E398FA2502
P2860
Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Precision-cut liver slices as ...... is to test antifibrotic drugs.
@en
Precision-cut liver slices as ...... is to test antifibrotic drugs.
@nl
type
label
Precision-cut liver slices as ...... is to test antifibrotic drugs.
@en
Precision-cut liver slices as ...... is to test antifibrotic drugs.
@nl
prefLabel
Precision-cut liver slices as ...... is to test antifibrotic drugs.
@en
Precision-cut liver slices as ...... is to test antifibrotic drugs.
@nl
P2093
P1476
Precision-cut liver slices as ...... is to test antifibrotic drugs.
@en
P2093
Dorenda Oosterhuis
Geny M M Groothuis
Inge M Westra
P304
P356
10.1016/J.TAAP.2013.11.017
P50
P577
2013-12-07T00:00:00Z